Post-ERCP pancreatitis in the Gastroenterology department of BMU

Authors

  • Md. Tasmir Arefin MD (Gastroenterology) Department of Gastroenterology, Bangladesh Medical University. Author
  • Dewan Saifuddin Ahmed Professor and Chairman, Department of Gastroenterology, Bangladesh Medical University. Author
  • Md. Masudur Rahman Khan Professor, Department of Gastroenterology, Bangladesh Medical University. Author
  • Md. Razibul Alam Professor, Department of Gastroenterology, Bangladesh Medical University. Author
  • Chanchal Kumar Ghosh Professor, Department of Gastroenterology, Bangladesh Medical University Author
  • Mohammad Shoaib Chowdhury Associate Professor, Department of Gastroenterology, Bangladesh Medical University Author
  • Md. Zahidur Rahman Associate Professor, Department of Gastroenterology, Bangladesh Medical University Author
  • A.B.M. Safiullah Associate Professor, Department of Gastroenterology, Bangladesh Medical University Author
  • Mohammad Asadur Rahman Associate Professor, Department of Gastroenterology, Bangladesh Medical University Author

Abstract

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic procedure used to treat pancreaticobiliary diseases. However, it poses significant risks, with post-ERCP pancreatitis (PEP) being the most common consequence, occurring in about 10.2% of cases. 

Objective: To assess the frequency and severity of post-ERCP pancreatitis. 

Materials & Methods: This prospective observational study was conducted among consecutive patients who underwent ERCP in the Department of Gastroenterology at Bangladesh Medical University (BMU), Dhaka, from December 2023 to February 2025. 

Results: A total of 272 participants were evaluated. The average age was 51.2 years, with 47.1% of participants male and 52.9% female. The most common indications of ERCP were choledocholithiasis (49.6%), cholangiocarcinoma (12.1%) and papillary stenosis (10.7%). Overall, 8.8% of participants developed post-ERCP pancreatitis (PEP), 7% had mild PEP, and 1.8% had moderate PEP. No participant developed any severe PEP. 

Downloads

Published

2026-01-10

Issue

Vol. 1 No. 2 (2026): Volume 1 · Issue 2 · January 2026

Section

Original Article